Overview

Study of IMC-11F8 in Participants With Colorectal Cancer

Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if IMC-11F8 in combination with chemotherapy is effective in treating colorectal cancer (CRC).
Phase:
Phase 2
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Antibodies, Monoclonal
Folic Acid
Leucovorin
Levoleucovorin
Necitumumab
Oxaliplatin